Bingham Private Wealth LLC purchased a new position in shares of McKesson Corporation (NYSE:MCK – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 702 shares of the company’s stock, valued at approximately $576,000.
Other large investors have also made changes to their positions in the company. GGM Financials LLC acquired a new stake in shares of McKesson during the 3rd quarter worth approximately $25,000. State of Wyoming acquired a new stake in shares of McKesson during the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson during the 3rd quarter worth approximately $31,000. Board of the Pension Protection Fund acquired a new stake in shares of McKesson during the 4th quarter worth approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson during the 3rd quarter worth approximately $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on MCK shares. Mizuho increased their price target on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. TD Cowen increased their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Evercore reissued an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Bank of America dropped their price objective on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating for the company in a research note on Monday, April 6th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research note on Thursday, January 29th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $970.93.
Insider Buying and Selling at McKesson
In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares of the company’s stock, valued at $2,824,605. The trade was a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,592 shares of company stock worth $3,518,555 over the last ninety days. Insiders own 0.08% of the company’s stock.
McKesson Price Performance
Shares of NYSE:MCK opened at $862.77 on Wednesday. The company has a market cap of $105.68 billion, a price-to-earnings ratio of 24.81, a PEG ratio of 1.25 and a beta of 0.42. The firm has a 50 day simple moving average of $916.80 and a 200 day simple moving average of $853.48. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00.
McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts expect that McKesson Corporation will post 32.77 EPS for the current year.
McKesson Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were paid a dividend of $0.82 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.
McKesson Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Recommended Stories
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
